Baldur Sveinbjørnsson and Øystein Rekdal - Free people check

(1 - 16 from 17

)

Events - Lytix Biopharma

lytixbiopharma.com

Attending: Andrew Saunders, Øystein Rekdal, Baldur Sveinbjørnsson, Håkan Wickholm & Vibeke Sundvold Gjerstad

News Detail - Lytix Biopharma

www.lytixbiopharma.com

Øystein Rekdal (CSO) and Baldur Sveinbjørnsson (Senior researcher) represented Lytix Biopharma at the 14th CIMT Annual Meeting in Mainz, ...

Safety, antitumor activity, and T-cell responses in a dose ...

kclpure.kcl.ac.uk

by J Spicer · · Cited by 11 — ... Hamina Patel, Jer ôme Galon, Fabienne Hermitte, Ketil Andre Camilio, Brynjar Mauseth, Vibeke Sundvold, Baldur Sveinbjørnsson & 1 more Øystein Rekdal. › portal › publications

期刊界All Journals 搜尽天下杂志传播学术成果专业期刊搜索期刊信息 ...

cnjournals.com

Ketil André Camilio Gerd Berge Chandra Sekhar Ravuri Øystein Rekdal Baldur Sveinbjørnsson 《Cancer immunology, immunotherapy : CII》2014,63(6): › search_by_au...

AACR 2016: Abstracts Google Books Result

books.google.de

Ketil André Camilio,1 Baldur Sveinbjørnsson,2 Sylvie Maubant,3 Guillaume Serin,3 Jean-François Mirjolet,3 Francis Bichat,3 Øystein Rekdal2.

Recruitment of LC3 to damaged Golgi apparatus - PubMed

pubmed.ncbi.nlm.nih.gov

by LC Gomes-da-Silva · · Cited by 16 — ... Séverine Divoux , Marko Storch , Baldur Sveinbjørnsson , Øystein Rekdal , Luis G Arnaut , Oliver Kepp , Guido Kroemer , Franck Perez ... › ...

Complete regression and systemic protective immune responses obtained...

www.ncbi.nlm.nih.gov

Conflict of interest. Gerd Berge and Chandra Sekhar Ravuri declare that they have no conflict of interest. Ketil André Camilio and Baldur Sveinbjørnsson receive financial support by and are shareholders in Lytix Biopharma AS. Øystein Rekdal is a partial owner and a shareholder in Lytix Biopharma AS.

Complete regression and systemic protective immune responses obtained...

link.springer.com

Ketil André Camilio,; Gerd Berge,; Chandra Sekhar Ravuri,; Øystein Rekdal,; Baldur Sveinbjørnsson … show all 5 hide. Download PDF (2,

Lytix Biopharma AS (6BG.F) Firmenprofil und Fakten

de.finance.yahoo.com

Dr. Oystein Rekdal, Co-Founder & CEO, 416,51k ; Mr. Gjest Breistein M.Sc. Chief Financial Officer, N/A ; Dr. Baldur Sveinbjørnsson Ph.D. · Chief Scientific Officer ... › profile

AG Echchannaoui/Theobald » Collaborations

www.unimedizin-mainz.de

Dr. Baldur Sveinbjørnsson (Director Scientific Research), Dr. Øystein Rekdal (CSO), Lytix Biopharma, Oslo, Norway. Print. Letzte Aktualisierung: › c...

Biotekmyggen Lytix satser på «Big Pharma»-oppkjøp - E24

e24.no

LANG REISE: Lytix-sjef Øystein Rekdal sammen med selskapets forskningssjef Baldur Sveinbjørnsson på hovedkontoret på Skøyen i Oslo. › boers-og-finans › bio...

Management Team - Lytix Biopharma

www.lytixbiopharma.com

Øystein Rekdal, PhD, CEO · Gjest Breistein, MSc, CFO · Baldur Sveinbjørnsson, PhD, CSO · Gry Stensrud, PhD, CTO · Graeme Currie, PhD, CDO. › management-team

WO A1 - Immune checkpoint inhibitor combinations

patents.google.com

Inventors, Liv Marie EIKE, Ketil CAMILIO, Baldur SVEINBJØRNSSON, Laurence Zitvogel, Takahiro Yamazaki, Øystein REKDAL, John Sigurd ...

WO A2 - Inhibition of tumour growth Google Patents

patents.google.com

Other languages: English: French; Inventor: Øystein REKDAL: John Sigurd Svendsen: Baldur SVEINBJØRNSSON: Gerd Berge: Live Tone Eliassen; Original Assignee: Lytix Biopharma As: Gardner, Rebecca, Katherine; Priority date. The priority date is an assumption and is not a legal conclusion. Google has not performed ...

John Inge Johnsen
Chandra Sekhar

People
Forename "Baldur" (99)
Name "Sveinbjørnsson" (2)

sorted by relevance / date

Advanced Search

Search name: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Baldur Sveinbjørnsson and Øystein Rekdal Free People Check

Events - Lytix Biopharma

News Detail - Lytix Biopharma

Safety, antitumor activity, and T-cell responses in a dose ...

期刊界All Journals 搜尽天下杂志传播学术成果专业期刊搜索期刊信息 ...

AACR 2016: Abstracts Google Books Result

Recruitment of LC3 to damaged Golgi apparatus - PubMed

Complete regression and systemic protective immune responses obtained...

Complete regression and systemic protective immune responses obtained...

Lytix Biopharma AS (6BG.F) Firmenprofil und Fakten

AG Echchannaoui/Theobald » Collaborations

Biotekmyggen Lytix satser på «Big Pharma»-oppkjøp - E24

Management Team - Lytix Biopharma

WO A1 - Immune checkpoint inhibitor combinations

WO A2 - Inhibition of tumour growth Google Patents

The oncolytic peptide LTX-315 induces cell death and DAMP release by...

Publications - Lytix Biopharma

All web results to the name "Baldur Sveinbjørnsson"